Results 91 to 100 of about 10,095 (153)

Nail lichen planus associated with imatinib mesylate. [PDF]

JAAD Case Rep
Axler E, Loesch E, Vaidya T, Neubauer Z, Lipner SR.   +4 more
europepmc   +1 more source

Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK Signaling. [PDF]

Biomedicines, 2021
Montella L, Ottaviano M, Riccio V, Picozzi F, Facchini G, Insabato L, Giuliano M, Palmieri G.   +7 more
europepmc   +1 more source

Successful treatment of metastatic dermatofibrosarcoma protuberans of the breast to the lungs with imatinib mesylate: a case report. [PDF]

Ecancermedicalscience
Kpatsi S, Daniels J, Kyei KA, Vanderpuye V.   +3 more
europepmc   +1 more source

In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery. [PDF]

Int J Nanomedicine, 2021
Xu H, Ji H, Li Z, Qiao W, Wang C, Tang J.   +5 more
europepmc   +1 more source

Compatibility Studies of Different Crystal Forms of Imatinib Mesylate with Pharmaceutical Excipients. [PDF]

ACS Omega
Mou Y, Zhao Y, Wen S, Li X, Zhang W, Xu X, Wang Y.   +6 more
europepmc   +1 more source

Imatinib Mesylate-Induced Acquired Dermal Melanocytosis and Acquired Bilateral Nevus of Ota-Like Macules. [PDF]

Ann Dermatol, 2021
Jang JW, Song CH, Jung YJ, Cheon DU, Koh WS, Ro YS, Ko JY.   +6 more
europepmc   +1 more source

Toxicity assessment of imatinib mesylate and a related impurity: in vitro and in vivo approaches. [PDF]

Toxicol Res (Camb)
Rocha CFRDS, Hermmann BS, Kayser JM, Zimmermann Prado Rodrigues G, Gehlen G, Boaretto FBM, Picada JN, Fleck JD, Charão MF, Verza SG.   +9 more
europepmc   +1 more source

Imatinib Mesylate for the Treatment of Canine Mast Cell Tumors: Assessment of the Response and Adverse Events in Comparison with the Conventional Therapy with Vinblastine and Prednisone. [PDF]

Cells, 2022
Macedo TR, de Queiroz GF, Casagrande TAC, Alexandre PA, Brandão PE, Fukumasu H, Melo SR, Dagli MLZ, Pinto ACBCF, Matera JM.   +9 more
europepmc   +1 more source

Claudin-1 Contributes to Gastrointestinal Stromal Tumors (GIST) Resistance to Imatinib Mesylate (IM) via Regulation of FGFR-Signaling. [PDF]

Int J Mol Sci
Boichuk S, Bikinieva F, Dunaev P, Galembikova A, Mikheeva E, Valeeva E, Mani S, Khromova N, Kopnin P, Shigapova L, Deviatiiarov R, Shagimardanova E, Ryzhkin S, Sabirov A.   +13 more
europepmc   +1 more source

Imatinib mesylate promotes melanogenesis through the modulation of p38 and MITF in murine cells. [PDF]

Toxicol Res
Talapphet N, Kim MM.
europepmc   +1 more source